Quinlan James P. 4
4 · Medicus Pharma Ltd. · Filed Aug 14, 2025
Insider Transaction Report
Form 4
Quinlan James P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Shares, no par value ("Common Shares")
2025-08-13$0.81/sh+125,000$101,250→ 254,147 total - Exercise/Conversion
Common Shares
2025-08-13$2.75/sh+20,000$55,000→ 274,147 total - Exercise/Conversion
Stock Option (right to buy)
2025-08-13−125,000→ 0 totalExercise: $0.81Exp: 2028-10-24→ Common Shares (125,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-08-13−20,000→ 0 totalExercise: $2.75Exp: 2029-12-17→ Common Shares (20,000 underlying)
Footnotes (3)
- [F1]Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
- [F2]Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
- [F3]The option was vested and was exercisable as of the Transaction Date.